ABOS · Acumen Pharmaceuticals, Inc. · Documents
$1.98
-0.08 (-3.88%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, management has concluded that substantial doubt exists regarding our ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$145.36M
Shares
72.32M
Volume · Oct 23
541.79K
Avg daily vol (3M)
458.35K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-08-08 | — | |
| 8-K | — | 2023-07-20 | 2023-07-18 | |
| 8-K | — | 2023-07-17 | 2023-07-16 | |
| 8-K | — | 2023-07-17 | — | |
| 8-K | — | 2023-06-08 | 2023-06-06 | |
| 10-Q | — | 2023-05-09 | 2023-03-31 | |
| 8-K | — | 2023-05-09 | — | |
| DEF 14A | — | 2023-04-27 | 2023-06-06 | |
| 8-K | — | 2023-04-27 | — | |
| 10-K | — | 2023-03-27 | 2022-12-31 | |
| 8-K | — | 2023-03-27 | — | |
| 8-K | — | 2023-03-15 | 2023-03-09 | |
| 8-K | — | 2023-02-01 | — | |
| 8-K | — | 2023-01-04 | 2023-01-03 | |
| 8-K | — | 2022-11-14 | — | |
| 10-Q | — | 2022-11-14 | 2022-09-30 | |
| 8-K | — | 2022-10-24 | — | |
| 8-K | — | 2022-09-12 | — | |
| 8-K | — | 2022-08-15 | 2022-08-12 | |
| 10-Q | — | 2022-08-15 | 2022-06-30 | |
| 8-K | — | 2022-08-01 | — | |
| 8-K | — | 2022-06-21 | 2022-06-15 | |
| 8-K | — | 2022-05-16 | — | |
| 10-Q | — | 2022-05-16 | 2022-03-31 | |
| DEF 14A | — | 2022-04-27 | 2022-06-15 | |
| 8-K | — | 2022-03-28 | — | |
| 10-K | — | 2022-03-28 | 2021-12-31 | |
| 8-K | — | 2022-01-03 | 2022-01-01 | |
| 8-K | — | 2021-11-15 | — | |
| 10-Q | — | 2021-11-15 | 2021-09-30 | |
| 8-K | — | 2021-11-10 | — | |
| 8-K | — | 2021-10-07 | — | |
| 8-K | — | 2021-08-31 | — | |
| 8-K | — | 2021-08-16 | — | |
| 10-Q | — | 2021-08-16 | 2021-06-30 | |
| 8-K | — | 2021-07-07 | 2021-07-06 |
Showing 51–86 of 86 filings